Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19

Dobaño, Carlota and Ramírez-Morros, Anna and Alonso, Selena and Vidal-Alaball, Josep and Ruiz-Olalla, Gemma and Vidal, Marta and Rubio, Rocío and Cascant, Emma and Parras, Daniel and Rodrigo Melero, Natalia and Serra, Pau and Carolis, Carlo and Santamaria, Pere and Forcada, Anna and Mendioroz, Jacobo and Aguilar, Ruth and Moncunill, Gemma and Ruiz-Comellas, Anna (2021) Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19. BMC Medicine, 19 (1). ISSN 1741-7015

[thumbnail of s12916-021-02032-2.pdf] Text
s12916-021-02032-2.pdf - Published Version

Download (627kB)

Abstract

We assessed the duration and baseline determinants of antibody responses to SARS-CoV-2 spike antigens and the occurrence of reinfections in a prospective cohort of 173 Spanish primary health care worker patients followed initially for 9 months and subsequently up to 12.5 months after COVID-19 symptoms onset. Seropositivity to SARS-CoV-2 spike and receptor-binding domain antigens up to 149–270 days was 92.49% (90.17% IgG, 76.3% IgA, 60.69% IgM). In a subset of 64 health care workers who had not yet been vaccinated by April 2021, seropositivity was 96.88% (95.31% IgG, 82.81% IgA) up to 322–379 days post symptoms onset. Four suspected reinfections were detected by passive case detection, two among seronegative individuals (5 and 7 months after the first episode), and one low antibody responder. Antibody levels significantly correlated with fever, hospitalization, anosmia/hypogeusia, allergies, smoking, and occupation. Stable sustainment of IgG responses raises hope for long-lasting COVID-19 vaccine immunity.

Item Type: Article
Subjects: ArticleGate > Medical Science
Depositing User: APLOS Lib
Date Deposited: 14 Jul 2022 03:58
Last Modified: 14 Jul 2022 03:58
URI: http://ebooks.pubstmlibrary.com/id/eprint/351

Actions (login required)

View Item
View Item